Cindy Eckert

Cindy Eckert, CEO and Founder of Sprout Pharmaceuticals, made history by bringing Addyi — the first and only FDA-approved drug for hypoactive sexual desire disorder (HSDD) in women, also known as low libido — to market. In 2015, Eckert sold Sprout Pharmaceuticals for a record-breaking $1 billion. She later fought to reacquire the company and reclaim control of Addyi to continue her mission of breaking down barriers in women’s sexual health and fighting for gender equity in healthcare. As a celebrated entrepreneur and fierce advocate for women’s sexual health with over 25 years of experience in sexual wellness and pharmaceuticals, Eckert’s impact extends beyond pharmaceuticals - she is known for her bold approach to business, commitment to fighting gender bias in medicine, and her fierc...